digital currency moon, searches

Suzhou Industrial Park Phase II Industrial Investment Fund registered and established with a capital contribution of 10 billion yuan. According to Tianyancha App, Suzhou Industrial Park Phase II Industrial Investment Fund (Limited Partnership) was recently established, with Suzhou Yuanfeng Capital Management Co., Ltd. as the executive partner, with a capital contribution of 10.01 billion yuan, and its business scope covers private equity investment fund management and venture capital fund management services. According to the partner information, the fund is jointly funded by Suzhou Industrial Park State-owned Capital Investment Operation Holding Co., Ltd., Suzhou Industrial Park Economic Development Co., Ltd. and Suzhou Yuanfeng Capital Management Co., Ltd.Morgan Stanley published a research report that China's monetary policy changed from "prudent" to "moderately loose" to support market sentiment in 2025, and the real policy may focus on interest rate reform in 2025. Morgan Stanley said that the increased attention to reactivating the capital market should also help support market sentiment and keep the trading volume high in the short term. The bank also suggested that optimizing existing loans, more rational bank loan growth and interest rate reform may be the real focus in 2025. The bank believes that risk-based loan pricing may continue to recover, which will help to buffer the bank's net interest margin, even if some additional loan market quotations are lowered.The South Korean police demanded that 11 people, including Premier Han Dezhu, be investigated. On December 10th, local time, the special investigation team of the National Investigation Headquarters of the South Korean Police Department, which is responsible for investigating the emergency martial law, said that 11 people, including State Councilor Han Dezhu and Zhao Taiyong, president of the National Intelligence Agency, had been asked to investigate. (CCTV News)

Lei Jun said that Xiaomi YU7 is currently undergoing a large-scale road test and is expected to be officially listed in June and July next year.AI application direction rose and strengthened. Many stocks such as Hanwang Technology rose and strengthened, while Hanwang Technology, Aofei Entertainment, Tianyue Digital, Bona Film and Jincai Internet rose, while Haitian Ruisheng, Iflytek, Fushi Holdings and Sanliuling followed suit.Commercial banks strengthen the marketing of personal pension business. According to combing, the "marketing fever" of personal pension business of ICBC, Agricultural Bank, China Construction Bank, Bank of China, Bank of Communications and other banks and their branches is heating up continuously recently. In addition, some banks have stepped up their efforts to "grab food" from the cake of personal pension business with the help of Internet financial platforms such as Jingdong Finance, and added more customers. The experts interviewed believe that it is an important measure for banks and other institutions to carry out personal pension business to implement the national strategy of actively responding to the aging population, which will help promote the implementation of personal pension policy. For banks, personal pension business can increase customer resources and provide a broader market space for bank wealth management business. (Securities Daily)

Significant progress in domestic growth hormone! Jichuan Pharmaceutical Co., Ltd. and Tianjing Biological Co., Ltd. announced that the listing application of Etan long-acting growth hormone was accepted, with a height of 10.76 cm a year, which made significant progress in domestic growth hormone. Today, Tianjing Bio and Jichuan Pharmaceutical jointly announced that the application for marketing biological products of Etan long-acting recombinant human growth hormone injection (hereinafter referred to as "Etan long-acting growth hormone") for treating children's growth hormone deficiency (PGHD) has been accepted by NMPA. As the first and only long-acting growth hormone with fusion protein in the domestic application stage and listed products, this innovative therapy is expected to provide safe, effective and convenient treatment options for children with growth hormone deficiency. Etan long-acting growth hormone adopts innovative hyFc® fusion protein technology, which greatly improves the stability and half-life of the drug by combining human growth hormone with specially designed human immunoglobulin. This patented technology not only ensures the biological activity of growth hormone, but also realizes the long-acting function of growth hormone in the body, thus making Ethan the first fusion protein long-acting growth hormone to be administered once a week.China's annual export rate in November was 6.7% in US dollars, with an expected 8.7% and a previous value of 12.70%. China's annual import rate in November was -3.9% in US dollars, with an expected 0.9% and a previous value of -2.30%.Navigation warning! In the sea shooting test in the southern part of the Yellow Sea, Lianyungang Maritime Safety Administration issued a navigation warning. From 8: 00 to 14: 00 on December 11, some sea areas in the southern part of the Yellow Sea were fired with live ammunition, and it was forbidden to enter. (Website of China Maritime Safety Administration)